Ipca Laboratories Limited (IPCALAB.NS)
INR 1368.0
(2.78%)
INR 1368.0
(2.78%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 77.05 Billion | 62.44 Billion | 57.66 Billion | 53.4 Billion | 45.58 Billion | 36.92 Billion |
| Cost of Revenue | 28.47 Billion | 23.06 Billion | 21.05 Billion | 18.01 Billion | 17.08 Billion | 12.9 Billion |
| Gross Profit | 48.58 Billion | 39.37 Billion | 36.6 Billion | 35.39 Billion | 28.49 Billion | 24.01 Billion |
| Operating Expenses | 18.98 Billion | 32.72 Billion | 25.97 Billion | 22.18 Billion | 21.05 Billion | 18.66 Billion |
| Selling, General and Administrative Expenses | 17.32 Billion | 6.32 Billion | 4.43 Billion | 3.95 Billion | 3.9 Billion | 3.74 Billion |
| Research and Development Expenses | 1.66 Billion | 461.3 Million | 418 Million | 523.8 Million | 313.8 Million | 207.4 Million |
| Other Expenses | - | 1.25 Billion | 155.7 Million | 144.8 Million | 201.9 Million | 210.7 Million |
| Cost and Expenses | 47.46 Billion | 55.79 Billion | 47.03 Billion | 40.2 Billion | 38.14 Billion | 31.57 Billion |
| Operating Income | 29.59 Billion | 7.03 Billion | 10.59 Billion | 13.14 Billion | 7.42 Billion | 5.31 Billion |
| Interest Expense | 1.38 Billion | 455.4 Million | 72.4 Million | 86.1 Million | 158.4 Million | 183 Million |
| Income Tax Expense | 3.13 Billion | 2.53 Billion | 2.24 Billion | 2.4 Billion | 1.35 Billion | 1.04 Billion |
| Earnings before Tax | 8.42 Billion | 7.45 Billion | 11.35 Billion | 13.81 Billion | 7.38 Billion | 5.46 Billion |
| Net Income | 5.47 Billion | 4.71 Billion | 8.84 Billion | 11.4 Billion | 6.06 Billion | 4.44 Billion |
| Earnings Per Share Basic | 21.57 | 18.58 | 34.85 | 45.01 | 24.00 | 17.61 |
| Earnings Per Share Diluted | 21.57 | 18.58 | 34.85 | 45.01 | 23.98 | 17.61 |
| Weighted Average Shares Outstanding | 253.7 Million | 253.7 Million | 253.7 Million | 253.27 Million | 252.65 Million | 252.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 253.7 Million | 253.7 Million | 253.7 Million | 253.27 Million | 252.88 Million | 252.65 Million |
| Gross Margin | 0.63 | 0.63 | 0.63 | 0.66 | 0.63 | 0.65 |
| EBIT Margin | 0.17 | 0.17 | 0.24 | 0.30 | 0.22 | 0.20 |
| Profit Margin | 0.07 | 0.08 | 0.15 | 0.21 | 0.13 | 0.12 |
| EBITDA | 13.29 Billion | 10.52 Billion | 13.78 Billion | 16.09 Billion | 9.76 Billion | 7.49 Billion |
| Earnings Before Tax Margin | 0.38 | 0.11 | 0.18 | 0.25 | 0.16 | 0.14 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 20.92 Billion | 20.33 Billion | 77.05 Billion | 20.52 Billion | 20.33 Billion | 15.87 Billion |
| Cost of Revenue | 12.3 Billion | 12.5 Billion | 46.41 Billion | 6.96 Billion | 6.77 Billion | 5.15 Billion |
| Gross Profit | 8.62 Billion | 7.82 Billion | 30.63 Billion | 13.55 Billion | 13.56 Billion | 10.72 Billion |
| Operating Expenses | 5.68 Billion | 6.84 Billion | 22.25 Billion | 11.24 Billion | 11.25 Billion | 8.33 Billion |
| Selling, General and Administrative Expenses | 5.68 Billion | 6.84 Billion | - | 5.65 Billion | 5.69 Billion | 3.57 Billion |
| Research and Development Expenses | - | 1.66 Billion | - | - | - | - |
| Other Expenses | 206.1 Million | 189.2 Million | 1.24 Billion | 224.5 Million | 385.5 Million | 448.5 Million |
| Cost and Expenses | 17.98 Billion | 19.34 Billion | 68.66 Billion | 18.21 Billion | 18.03 Billion | 13.49 Billion |
| Operating Income | 2.93 Billion | 981.5 Million | 8.38 Billion | 2.54 Billion | 2.69 Billion | 2.38 Billion |
| Interest Expense | 240.5 Million | 293.7 Million | 1.38 Billion | 334 Million | 441.2 Million | 313.8 Million |
| Income Tax Expense | 914.1 Million | 736.9 Million | 3.13 Billion | 662.4 Million | 879.2 Million | 856.1 Million |
| Earnings before Tax | 2.9 Billion | 766 Million | 8.42 Billion | 2.88 Billion | 2.25 Billion | 2.51 Billion |
| Net Income | 1.92 Billion | 595.9 Million | 5.47 Billion | 1.79 Billion | 1.45 Billion | 1.62 Billion |
| Earnings Per Share Basic | 7.58 | 2.35 | - | 7.09 | 5.72 | 6.42 |
| Earnings Per Share Diluted | 7.58 | 2.35 | - | 7.09 | 5.72 | 6.42 |
| Weighted Average Shares Outstanding | 253.7 Million | 253.7 Million | 211.98 Million | 253.7 Million | 253.6 Million | 253.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 253.7 Million | 253.7 Million | 211.98 Million | 253.7 Million | 253.6 Million | 253.61 Million |
| Gross Margin | 0.41 | 0.39 | 0.40 | 0.66 | 0.67 | 0.68 |
| EBIT Margin | 0.19 | 0.10 | - | 0.17 | 0.18 | 0.22 |
| Profit Margin | 0.09 | 0.03 | 0.07 | 0.09 | 0.07 | 0.10 |
| EBITDA | 3.92 Billion | 1.96 Billion | - | 3.53 Billion | 3.59 Billion | 3.52 Billion |
| Earnings Before Tax Margin | 0.14 | 0.05 | 0.11 | 0.12 | 0.13 | 0.15 |
ORIENTCEM
IFBC
OLATECH
1712
TLTFF
600165